Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 35M | 18.2% |
| Gross Profit | 24M | 17.2% |
| Cost of Revenue | 35M | 8.6% |
| Operating expense | 33M | 3.9% |
| Net Income | -6.1M | 33.2% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 305M | 66.8% |
| Total Liabilities | 30M | 57.5% |
| Total Equity | 275M | 67.9% |
| Shares Outstanding | 40M | 6.6% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -4M | 56.7% |
| Cash from investing | -116M | 576.4% |
| Cash from financing | 111M | 1294.8% |
EPS
Financial Highlights for RxSight in Q2 '24
RxSight reported a revenue of 35M, which is a 18.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 24M, marking a 17.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 35M, a 8.6% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 33M, showing a 3.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -6.1M, showing a 33.2% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
It was a positive quarter for RxSight with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
